text:
So Entrepreneurial
Nick Hughes on entrepreneurship
Startups and Projects
Tag Archives: IPO
$99,970,000,000 is The Difference Between These 3 Decisions
Posted on July 3, 2011 by Nick Hughes
If MySpace would have just copied Facebook, it would have been Facebook – Sean Parker
That was Sean Parker's answer to the question "what happened to MySpace?" in a recent interview with Jimmy Fallon. This got me thinking and was the needle prick I needed to start on a topic I have wanted to write about for some time.
If you can remember at one time MySpace was the social networking behemoth, holding the crown as the largest site on the web. "Do you have a MySpace?" was the proverbial question between twenty-somethings. They had over a hundred million users worldwide, were driving revenue in the hundreds of millions of dollars and it looked as though we had an MTV 2.0 on our hands. They made headlines with the acceptance of a $580 million acquisition from News Corp, validating Social Networking as a ligament startup business venture. Little did we know they would turn out to be a joke, an afterthought on the web and a huge lesson to any young founder looking to build the next big company.
At right is a snapshot of the MySpace.com monthly unique users from earlier this year (courtesy of Techcrunch). As you can see (and probably already knew) usage has continued to plummet. MySpace is literally a ghost town at the same time Facebook has grown to the largest site in the world, officially eclipsing 700 million users on their way to an inevitable 1 billion users and will soon IPO with a valuation of more than $100 billion! This begs the question: What happened?
My take from Parker's statement is MySpace had such a massive lead in users, media coverage as well as total mindshare in the social networking space it was their race to loose. Quickly incorporating the features they saw Facebook releasing could have helped them stay atop the game. Imagine what MySpace would be worth now if all they did was manage to keep it all together and ride out this new wave of social/mobile web. Definitely more than the rumored $30 million News Corp is looking for to get them off their books. What a sad ending to once dominant company. To take Parker's statement a bit further, I argue the biggest mistake MySpace made was sell out to the suits for a mere $580 million. Here are three key differences that add up to a $99,970,000,000 difference between Facebook and MySpace.
Lack of vision and Leadership
The biggest difference between Facebook and MySpace is an intangible I have written about it extensively before. Just as the difference between Apple and Microsoft was found in Leadership, so too was the difference between the social networking companies Facebook and MySpace. (Get used to me writing about vision and leadership because I believe it is the number one reason companies succeed or fail.) MySpace was early out of the gate and sprinted the first mile but did not foresee what could possible be on the horizon. All they knew was people wanted a page to customize as their own and maybe a place find and connect with others. But who was leading MySpace? To put it bluntly, MySpace had no clue what they were doing and no clue who to look towards for leadership. MySpace was not created by a visionary such as Mark Zuckerberg, who saw something in the web most did not. They were driving solely on dollars and revenue, and the lack of vision and focus devastated MySpace's growth in the end.
If Facebook was only a profile page where you can connect to your friends, MySpace would have won the race. Facebook bet (and won) on a vision of the personalized web, integrating our friends in almost everything we do in the digital world. Zuckerberg saw not only a web of information, but a web of people and set out to connect all those people into the web. Execution on this vision required laser focus from a passionate founder. MySpace ran the first mile faster but lost its way. Facebook knew the course and won the marathon.
Message to entrepreneurs: Have the intelligence to place a visionary leader at the heart of your company and let them guide the way.
Technically Inept
Myspace proved they were technically inept, lacking any engineering vision of how the web should work. According to a recent Bloomberg Businessweek tell-all article, the company was constantly at odds with leadership on how/what/where to innovate. "They were having to do all technical innovations to address the various panics that are happening. Basically their development cycle turned into one of crisis management, not one of innovation." Bottom line, MySpace lacked the vision as well as the technical edge necessary for a web company to maintain their dominant position.
More importantly, MySpace was not created as an innovative new platform built by forward thinking engineers. They were a company who decided to copy Friendster using sub-par technology but grew because they understood how to market their brand to the general public. Choice quote from the article: "Using .NET is like Fred Flintstone building a database," says David Siminoff, whose company owns the dating website JDate, which struggled with a similar platform issue. "The flexibility is minimal. It is hated by the developer community." Why did they choose to do this? Driven by revenue pressures they chose to skimp on technical details and focus on more ads.
On the contrary, Facebook was intended from the beginning to be a socially transformational technology built by smart engineers. Zuck made it a point that their engineers would determine the road ahead. They aimed to redefine the web and understood this would require major investment. As a non-technical executive, it was still obvious to me who was stronger in engineering talent between the two companies. Remember how refreshingly clean a Facebook profile felt vs the craziness that was a MySpace profile. MySpace chose to skimp on the engine and polish the chrome. Bad mistake.
In an interesting note, most close to Zuckerberg would admit the best decision he has ever made was to bring in a much senior and more businesslike Sheryl Sandberg as the Chief Operating Officer of Facebook. It is said she is in more direct managerial oversight than Zuck, and who would want that? Sandberg has been credited with building out Google's ad business, helping create a multi-billion dollar search ad business. I credit Mark for submitting his ego and filling holes with the right people, Facebook is better off for it. Looking at MySpace and their recent history I cannot say the same. Holes were not filled and egos were not subdued.
Message to entrepreneurs: Know where you are good, understand where you need to be great, and find the right people to fill the gaps.
Poor Culture Fit with News Corp
"I think any time a startup is acquired, there's always a certain amount of culture clash." – Chris Dewolfe, MySpace Co-founder and one time CEO.
The worst decision for the future of MySpace was to sell the company to News Corp. (Okay, the founders and initial investors made out fine, but the future of the company pretty much was set in stone.) Time and time again I observe or read about another startup being acquired by a larger company and I think to myself "well, there it goes…"
The blazing, crazy, edgy, partying, sometimes innovative culture of MySpace was suffocated by the bureaucracy of corporate New Corp. Do yourself a favor and think about your startup culture currently, and then think about the culture in a Microsoft, Google, Aol, or any other large corporation. Ask Dennis Crowley. Ask Evan Williams. Ask Caterina Fake. It usually doesn't end well when you sell your booming startup to a large corporation. Facebook fought off takeover bid after take over bid until everyone knew they just weren't ever going to be for sale. That's ballsy, but its also what has to happen if you want to see your vision come together.
Message for entrepreneurs: If you have a long term vision for your company, don't sell – ever! If you want to make some quick money, sell at the top of your hype – and walk away as early as you can. The post-acquisition company will be nothing like the pre-acquisition company.
I am tired of seeing innovative startups being gobbled up by larger corporations only to disappear off the face of the earth – this is not how innovation changes the world. It is actually how innovation is hindered. I understand, as a founder you are double minded building your company. You want to make a chunk of cheddar, and there's nothing wrong with that. Isn't that what going into business is all about? I understand… and I would want to do the same thing in your position.
But before you sign those papers I would step back and determine what you really want and if it's the best option. If you really need to sell, truth is you did not build the company correctly. If you want to cash in, great. But understand, odds are the world will no longer be changed by your innovation. If you really feel selling is the best option, think deep and hard about the culture inside your company as well as inside the potential acquirer because the marriage is going to be tough. And if you feel deep down in your heart your company has a great future, don't sell out. Just think about how News Corp and the original MySpace founders feel about this outcome right now.
Image courtesy of Flickr user UltraRob.
This post was originally published on BusinessInsider.com.
Follow @jnickhughes
Posted in Startups, Technology, The Web	/ Tagged Facebook, Failure, IPO, Myspace, MySpace Sold, Zuckerberg	/ Leave a comment
The Story of How Pandora Radio Almost Died
Posted on June 16, 2011 by Nick Hughes
I love the Pandora Radio app on my iphone. I listen to music most of the day – in my room or around the house, in my car, outside walking around – and this is possible only because of internet connected mobile devices. Pandora Radio just recently went public on the NYSE and looks to have a strong future. It wasn't always so bright, this is a story of persistence and hanging on by a thread. MG Siegler of Techcrunch had a great write-up on Pandora the day of their IPO, I think it's so I will re-post it below. I like it because you get a sense these founders would not give up on their vision and persevered through much trial and tribulation.
Pandora was founded in 2000, but it wasn't known as "Pandora" at the time. Instead, the company was focused on their Music Genome Project, which aimed to extract the DNA from music, as it were, and find commonalities to perfect recommendations. When Conrad joined in 2004, the company was known as Savage Beast — yes, a truly awful name that invokes Savage Garden. In fact, here's an early blog post from Conrad about Savage Beast that he probably won't be pleased with me sharing.
When Conrad came on board, the company had just taken its first real venture capital investment (from Walden Ventures) and Joe Kennedy had just been hired as CEO. The idea was to transform the Music Genome Project from a cool piece of technology that was licensed out to the likes of Best Buy, and (our parent) AOL, among others, to a consumer-facing product. That effort began in December 2004, with design work leading up to that. By the late summer of 2005, the product was ready to go.
And here's where things get really interesting.
"TechCrunch is a part of this," Conrad says. "We launched, and the first Barcamp was the following Saturday. I got out of bed that morning and almost didn't go. But at the last minute, I threw my laptop in the car and drove to Palo Alto," he says. "By luck, Mike was in the room."
He means, of course, Mike Arrington.
"He got up when it was over, went to a Starbucks, I think, and wrote a post about Pandora. That was the starter pistol for our early growth," Conrad says. And thanks to the magic of the Internet, you too can see that post from August 20, 2005 right here (note the part where Arrington tries to give out invites from his personal email address, then gives up due to massive interest).
Conrad notes that TechCrunch itself was "about 45 days old" at that point. And he fondly remembers Arrington being annoyed with him that the Pandora launch wasn't given to him as an exclusive. "At that point, he was just some blogger to me," Conrad says with a laugh.
But that didn't stop Conrad from showing up at Arrington's house over the next several months for the BBQs Arrington used to host in his backyard. Conrad recalls that Pandora music streaming from his laptop would often be the musical entertainment for the evening "while we stood around his little campfire".
From that point on, Pandora "grew at a pace that exceeded my expectations," Conrad says noting that millions of users were coming on in just the opening years.
But then the CRB decided the royalties for this new form of radio, Internet radio, needed to be set. Conrad notes that after Pandora was live for about a year and a half, those rates were revealed — and they weren't good. "It was economically unsound," he says. "And it wasn't just us that was affected; Yahoo, AOL, Microsoft, and a lot of smaller guys too." At that point, Pandora entered into a two-year-long process of negotiating with the record labels over royalties that led to the situation described at the beginning of this post. "This was a complicated period for us," Conrad says.
But there was also a ray of hope that emerged during this time. The App Store.
Conrad notes that when the iPhone OS 3 (remember, it wasn't "iOS" at the time) launched in the summer of 2008 and brought the third-party-friendly App Store for the first time, everything changed. "Broadly, the smartphone category accelerated everything for us," he says, noting that the App Store was the catalyst.
"What we're really trying to do is re-invent radio. It was consumed everywhere, but least of all at work, and the web browser changed that," Conrad says. "But the mobile devices took it out of the browser and out into the world," he continues. Now over half of Pandora's usage comes on smartphone devices, he says. And that's incredible since Pandora had been on feature phones for about a year prior to the App Store, but it wasn't going anywhere. With the iPhone, "the consumer expectation of what they could do with their phone changed drastically," he says.
Conrad also points out that Nielsen had a recent study which put Pandora in the top five apps in terms of usage on major devices — iPhone, iPad, Android, Blackberry. He believes they're the only company in the top five on each of those devices.
So the App Store helped Pandora's mood in an otherwise bleak time. "The timelines do overlap in an interesting way," Conrad says. But at the same time, he says that he was never too concerned for Pandora having to completely shut down. "The [royalty] rates were so irrational that we were very confident through the period that we would come to a compromise with the rights' holders," he says. At the same time, he credits the "incredible outpouring of support from our listeners" as the thing that really motivated Congress to start looking into the situation.
"It was frustrating that it went on for so long, but we thought rationality would prevail," Conrad says. And even after "RIP, Good Times", hit in late 2008, he wasn't too worried because "we focused on the monetization of the product from the beginning." "Other companies were behind the eight ball, but we were starting to see the rewards from that attention to revenue," he says.
And then in the middle of 2009, the clouds broke. Pandora (and other Internet radio services) reached an agreement that would lower royalties to the point where the business could work. "Pandora is finally on safe ground with a long-term agreement for survivable royalty rates," Conrad told us at the time.
"A real period of growth started then." And today, Pandora has over 94 million registered users.
Story courtesy of Techcrunch
Posted in entrepreneurship, Startups	/ Tagged IPO, Music, Pandora, Radio, RIP	/ Leave a comment
Breaking: Who's in control of Groupon Now?
Posted on June 2, 2011 by Nick Hughes
Groupon files an S-1 for an Initial Public Offering today. Huge details revealed on Business Insider. The question now becomes: Who's in control of Groupon?
Lightbank partner Eric Lefkofsky owns 21% of the company's voting shares. Founder and CEO Andrew Mason owns 7.7%.
I am not sure if this is good or bad for the "web" but it sure is HUGE.
Posted in local commerce, Startups	/ Tagged Groupon, IPO	/ Leave a comment
Connect with Nick
Subscribe to Nick's blog
Join thousands on Founders Live!
Buy My New eBook on Amazon
I Was Just Told "You would not have made it through the weekend"
How To Properly Email Intro Two People
Here's Google's Homepage 1999 vs. 2012. Can You Tell The Difference?
Why I Cry During Horse Racing
I am going on a 2019 World Tour To Discover Talent, Inspiration... and Myself
Announcing Founders Live Insider – Premium Membership With Access To Perks and Experiences + Join Nick's Insider Council
World Tour 2019 Month NINE+TEN Overview – NYC, London and A Final Farewell To My Father
(PODCAST) – Special Episode of Catching Up With Conner and Nick – Life and Death
I'll Miss You Dad. The 3 Entrepreneurial Lessons My Father Taught Me
ANNOUNCEMENT – The Official Launch of The Founders Live Podcast. Listen To 001 – AK Ikwuakor of Elete Styles From Boston
My Interview on Folk Stories Podcast with Kevin Lin
NEW MASTERMIND: Founders Five – Master the 5 Essentials Required To Survive And Thrive As A Founder. Starts Oct 14th. Save $200 This Week!
ANNOUNCING – Founders Live Social Impact Program, Our Commitment To Entrepreneurial Equality And Your Opportunity To Join Us
Local Commerce
So Entrepreneurial 8
Archives Select Month November 2019 (1) October 2019 (6) September 2019 (2) August 2019 (1) July 2019 (2) June 2019 (2) May 2019 (2) April 2019 (1) March 2019 (3) February 2019 (2) January 2019 (3) December 2018 (2) August 2018 (1) April 2018 (2) October 2017 (1) August 2017 (1) November 2016 (1) October 2016 (1) September 2016 (1) July 2016 (3) June 2016 (1) May 2016 (2) April 2016 (1) January 2016 (3) December 2015 (5) November 2015 (6) October 2015 (3) September 2015 (2) August 2015 (4) July 2015 (4) February 2015 (1) January 2015 (3) December 2014 (2) November 2014 (7) October 2014 (5) June 2014 (1) May 2014 (6) April 2014 (6) March 2014 (1) February 2014 (3) January 2014 (2) December 2013 (5) November 2013 (7) October 2013 (13) September 2013 (10) August 2013 (13) July 2013 (11) June 2013 (13) May 2013 (8) April 2013 (9) March 2013 (11) February 2013 (12) January 2013 (7) December 2012 (1) November 2012 (11) October 2012 (6) September 2012 (9) August 2012 (5) July 2012 (11) June 2012 (15) May 2012 (14) April 2012 (10) March 2012 (11) February 2012 (9) January 2012 (12) December 2011 (11) November 2011 (8) October 2011 (6) September 2011 (9) August 2011 (13) July 2011 (19) June 2011 (35) May 2011 (19)


Metinvest, the international vertically integrated mining and metals company, as part of the long-term development strategy has commissioned a second set of magnetic and flotation concentrate finishing (MFDK) at Ingulets GOK. The total project budget was approximately $ 40 million.
26 December 2011 on the Sign sugar factory was put into operation the finished product storage capacity of 30,000 tons of sugar. His discovery has created an additional 60 jobs. The project cost is 55 million rubles.
There is a construction packing plant. In February 2012, it will be put into operation. The cost of the project is 135 million rubles. The number of workers in the packing section will be 80 people.
Volume loading on the network of JSC "Russian Railways" in 2011 was 1.24 billion tons, up 3% from the same period last year, according to the press service of JSC "Russian Railways".
Cargo turnover in 2011 amounted to 2130000000000 tariff ton-km (+5.7%), turnover with the mileage of cars unladen — 2.7 trillion tonne-km (8%).
Extraction of oil and gas condensate in 2011 increased by 1.2% — to 511.31 million tons. Russian oil exports in 2011 fell by 1.3% (3.16 million tons) compared to last year — up to 241.83 million tons.
According to the Ministry of Energy of Russia, December oil exports fell by 4.2% — up to 20 million 511 thousand tons.
In 2011, with the financial participation of RUSNANO and running more than 13 new productions for various products using nanotechnology.
May 2011 — RUSNANO has opened in Moscow on a pilot production project RMT producing thermoelectric cooling micronutrients. These components are used for cooling lasers, photodetectors, and integrated circuits.
Project Company Ltd. "RMT" participants: "RUSNANO", JSC "RMT" venture capital fund "S-Group Ventures' total budget of the project: 797 million rubles from RUSNANO 150 million rubles first thermoelectric modules that were released in a new production of LLC "RMT"
Russian Railways "signed a firm contract with the German company Siemens for the supply of eight high-speed trains" Peregrine Falcon ". According to" Interfax ", the total value of the contracts to the cost of maintenance of trains is 600 million euros.
According to President of Russian Railways Vladimir Yakunin, the cost of a single train of 37.1 million euros (eight — about 297 million). Deliveries "Peregrine" will begin in January 2014.
In 2011, the level of production of finished rolled steel in Russia is estimated at about 59.3 million tonnes That is an increase over 2010 of 2.2%. Production of rolled almost reached the level of 2007 (59.6 million tonnes) — 99.5%. This low rate of growth of production in the past year compared to 2010 with an increase in domestic consumption by 25.9% due to a high rate of growth of imports (20%), mainly from Asia and the Pacific (+43%). Compared with 2007, domestic consumption in 2011 increased by 8.6% (40.3 million tons against 37.1 million tons).


Honorable Mention in the 2018 PROSE Award in the category of Cultural Anthropology & Sociology, sponsored by the Professional and Scholarly Publishing Division, Association of American Publishers.
Neda Maghbouleh is Assistant Professor of Sociology at the University of Toronto.
"In this brilliant, beautifully written, and persuasive book, Maghbouleh demonstrates that Iranian Americans inhabit a complex and contradictory relationship to race. The poignant portraits of second-generation Iranian Americans reveal whiteness to be a volatile social construction, shaped by political, cultural, linguistic, and religious practices that initially might seem to have little to do with race."
"The Limits of Whiteness is cutting-edge scholarship at its best. Beautifully written and insightfully researched, it is essential reading for those interested in the fraught and capacious legacies, and afterlives, of Middle Eastern and American racial projects."
"I've been writing personal essays about Iranians and race for years, but Neda Maghbouleh's The Limits of Whiteness provides a much-needed sociologist's examination. Maghbouleh seamlessly navigates the historical, anthropological, and political, in a work as engaging as it is informative. This trailblazing book should be required reading for anyone interested in race in America, period."
"While there is much for a scholar or advanced graduate student of race, migration, or Middle East studies to glean from the text, the book would be a welcome addition to introductory courses in American studies, ethnic studies, anthropology, and sociology, and as shared family reading in Iranian American households. The book is a conversation starter and an insightful, timely analysis of what race means and feels like for brown youth at the limits of whiteness."
"While numerous sociological studies have examined how Jewish, Italian, and Irish Americans have "become white" over time,...Neda Maghbouleh is interested in how Iranian Americans and those of other Middle Eastern backgrounds have moved back and forth across the color line....Maghbouleh's book illustrates the inadequacy of existing studies of American whiteness."
"Social science studies on race and Iranians, especially full-length books, are few. So this book significantly contributes to the scarce but emerging research on Iranians in diaspora. It also endeavors to better situate the immigration scholarship with that of race. Lastly, The Limits of Whiteness comes at a time when discussions surrounding immigrants and their children continue to take center stage in American political discourse and immigration policy."


text:
Patient Journal
Neither many government hospitals nor much doctors existed In Lansdowne to take look after the patient's healthcare. Sheila was really touched upon by the treatment given by the The Hans Foundation hospital at a camp in Lansdowne. And as she repeatedly said "This is a great help to our lives"
Santosh is into her old age and has nobody to take care of her. Santosh had a cataract in her left eye. She found the doctors & support staff very co-operative and amiable. She had a successful surgery and was extremely happy that The Hans Foundation took care of her at such an old age.
Chain Singh
Chain Singh lives in a rural village of Liwari which is mostly disconnected with general health facilities.There were no government facilities for healthcare in his community. He had a poor vision but was treated successfully at a camp in Liwari
Baghwan Singh
Bhagwan Singh was travelling with his family in his car when due to snow on road, the car skid and fell into the valley.The entire family had a miraculous escape from this accident. While nobody sustained major injuries, Bhagwan Singh and the family is being treated at the hospital as of now.
Her cousin threw a chair at 9-year-old Kamini, seriously injuring her eye. Her father ran from pillar to post visiting different eye hospitals for his daughter's treatment. But, he was shown the door because he couldn't afford the treatment. A kind neighbourhood Ophthalmologist referred Kamini to The Hans Foundation Eye Care. In spite of not being fully equipped for general anaesthesia, we took her in. Our in-house physician giving IV sedation, we repaired her cornea and aspirated her ruptured lens. Now in the second phase, she will need corneal grafting and IOL implantation. For now, the worst is over.
Jay Singh
Sixty-Five-year-old Jay Singh begs for food to make a living. Facial palsy rendered his left eye open to infection and trauma. Plastic surgery at The Hans Foundation Eye Care corrected his damaged lower lid. Now he can close his left eye, and it is safe from the elements. With this happy story comes the sadness of knowing that Singh has no place to call home, and must go back to begging for food once again.
Kamla
Kamla lives in a small village in Nainital. She had cataract in both eyes. Her grandson brought her to us in Haridwar after navigating a large part of the Himalayan terrain, hoping she could undergo cataract eye surgery. Our ophthalmologists performed free physical exams and surgeries. Kamla can now see and her happiness knows no bounds.
Keshar Singh
Keshar Singh is an 80-year-old man full of energy and enthusiasm. He loves to talk about everything under the sun! The only thing that worries him is lack of proper healthcare in Pauri-Garhwal district. He himself is suffering from an orthopaedic issue and regularly visits The Hans Foundation Hospital in Satpuli for regular health check-ups. He says that his joints are getting better and he can now climb 4 kms uphill and pays Rs 100 to the local transport facility without any hesitation just to come at the facility. He is happy now and expresses his gratitude to the hospital staff and management for bringing healthcare to the people of his district and improving his own joint problems.
Mohar Singh
A blinding trachoma which is a form of chronic conjunctivitis made Mohar's eyelids turn inwards. The resulting eyelash-on-cornea also called the 'Windshield Wiper Effect' caused corneal scarring and blindness. To relieve Mohar of the windshield wiper effect, The Hans Foundation Eye Care Ophthalmologists performed free surgery on both his eyes. To heal his vision, the ophthalmologists are planning to perform corneal grafting, completely free of charge.
Mariam, a bride to be, lost her right eye to corneal ulcer during her childhood. The doctors at The Hans Foundation Eye Care operated on her eye, free of cost, putting in place an artificial ocular prosthesis (artificial eye). Although she cannot see with that artificial eye but the procedure has helped her in regaining her confidence and self-esteem.
Baba Bhagat Singh
Baba Bhagat Singh, a cataract blinded patient was operated at The Hans Foundation Eye Care. His vision from one eye has been restored and now that he can see again, he does not stumble and fall anymore and he can once again read the scriptures and perform daily chores. In the coming few weeks, his other eye will also be treated upon that will restore his complete vision.
Kashi Ram
Kashiram, a farmer by profession, had cataract and glaucoma in both his eyes. He belongs to a very backward rural region that lacks basic health amenities. A father to 4 children, Kashiram is the only bread earner of his family. He told us how blurred vision impeded his family's source of living and made their condition miserable. After our doctors performed surgeries on his eyes the vision improved remarkably and he his is able to work without any difficulty.

redpajama_set_name: RedPajamaCommonCrawl


text:
Alan D Bainbridge MRICS
Director of Workplace
Alan Bainbridge MRICS, Director for BBC Property, which has over 150 locations across the UK, Alan has over 30 years experience in construction, property and facilities management. His involvement in flagship schemes from PFI, retail, commercial and media has given him a breadth of understanding across the market from owner to occupier and across the supply chain. He directs an in-house team of 30 professionals who manage an outsourced team of over 800 across the UK. Alan led the delivery of the award winning transformational MediaCityUK in Salford for the BBC and the new headquarters for BBC Wales in Central Square, Cardiff. These were both major programmes of change, with property, people and facilities at the forefront. He is a passionate advocate of the role that property can play in business when done properly. He uses the expertise of construction professionals over product sales and is committed to using the best in British manufacturing and fabrication to support this. The delivery of Central Square Cardiff for Wales' new national headquarters has set a new world class standard, especially for accessibility in Workplace and FM design.
The Occupiers Perspective: Why workplaces are more important than ever
2020-10-08T09:00:00 - 2020-10-08T09:45:00


text:
Petropawliwka (ukrainisch ; russisch /) ist eine Siedlung städtischen Typs in der ukrainischen Oblast Dnipropetrowsk mit 8.563 Einwohnern (2013).

Die im Nordosten der Oblast liegende Siedlung liegt am Fluss Samara und ist das Zentrum des gleichnamigen Rajons Petropawliwka.

Zur Siedlungsratsgemeinde zählt auch die westlich des Flusses liegende Siedlung städtischen Typs Salisnytschne.

Geschichte
Der Siedlung wurde 1775 zum ersten Mal erwähnt. Seit 1957 hat sie den Status einer Siedlung städtischen Typs

Bevölkerung

Quelle:

Rajon

Der Rajon Petropawliwka, dessen administratives Zentrum der Ort ist, hat eine Fläche von 1248 km² und eine Bevölkerung von 28.340 Einwohnern (2012). Die Bevölkerungsdichte beträgt 23 Einwohnern pro km².

Persönlichkeiten
 Jelena Fjodorowna Rosmirowitsch (1886–1953), russische Revolutionärin

Weblinks

Einzelnachweise

Ort in der Oblast Dnipropetrowsk
Ersterwähnung 1775
Rajon Petropawliwka

redpajama_set_name: RedPajamaWikipedia


Exciting gameplay that is constantly moving forward. Fantastic use of cutscenes. Nice overall visual style.
Some of the acting can be stiff from time to time.
Get some popcorn, this hidden object game is an exciting ride.
Mysterious artifacts and adventurous treasure hunters are a well-established part of the hidden object genre. What you might not expect, though, are scores of live actors, exciting airship crashes, spirit-like races of beings, and frightfully malefic villains. Amaranthine Voyage: The Tree of Life has all of the excitement you'd expect from a summer blockbuster stuffed inside a hidden object game.
On your way to search for the mythical Tree of Life, you awake from a troubling nightmare. Apparently those red smoke-like spirits you dreamed about are more fact than fiction, as they're currently attacking the ship! You scramble to regain control but end up crashing in the jungle, narrowly escaping the grasp of one of the smoke beings. A benevolent blue wisp appears and points you towards a temple, beginning your journey across the realm to the Tree of Life. But first, you've got to deal with an evil dark force that's poisoning the land.
Amaranthine Voyage: The Tree of Life starts with a bang and never slows down. It's a hidden object adventure with a lot of punch, feeding you heaping spoonfuls of mini-games, hidden object scenes, and stretches of exploration between exciting cinematic cutscenes. It does all of this without complicating the gameplay or resorting to cheap tactics to add difficulty to the puzzles. It's a simple, straightforward game with an exciting story that unravels as you work your way through imaginative landscapes.
Most areas in Amaranthine Voyage keep you confined to just a few screens, allowing you to focus on hunting down one or two key items scattered throughout the environment. Puzzles are pretty simple to solve and never require more than a few steps. Hidden object scenes are evenly paced and end up being a bit on the short side, largely due to their straightforward nature. Items aren't hidden too obscurely, and most of what you need will be right in front of your eyes. Each scene has a few incomplete items you'll need to work with before you can collect them, like a locket without a chain or a piece of paper in need of a signature. At the end, you're presented with a rhyming riddle that gives you your only clue to the final item in the scene!
Amaranthine Voyage employs a number of live actors to play the part of some of the main characters. For the most part these hired hands do their jobs well, but there's always the occasional scene where it's a little too obvious the actor is standing in front of a green screen in a studio. The voice acting is also a little shaky at times, delivering lines that sound like a grade school teacher reading a book to her class. It's all in good fun, though, and Amaranthine Voyage never asks you to take anything too seriously. It's a fantasy-based casual adventure game, after all!
The hidden object genre needs a little spicing up from time to time, and Amaranthine Voyage: The Tree of Life is just the game to do it. With exciting storytelling and gameplay that remains lively throughout, you can't help but stay riveted to the screen. It's a little on the easy side, but with six chapters, tons of collectibles/achievements, and a good dose of extra content in the collector's edition, you won't be hurting for gameplay anytime soon.


text:
The Tuscarora Mountains are a mountain range in Elko and Eureka counties of northern, Nevada. The southern perimeter of the north-south mountain range is the Humboldt River and valley. The community of Tuscarora lies on the east flank of the range.

The range is named after the Tuscarora people.

References

Mountains
Mountain ranges of Nevada
Mountain ranges of Elko County, Nevada


Lisa Byrd Nesser has been living and working with Burmese/Myanmar refugees and minority groups in Chiang Mai for the last 14 years. She founded Thai Freedom House in 2005; a community language and arts learning center which provides free classes, seven days a week to vulnerable populations that would have nowhere else to turn. Volunteers from all over the world come to intern and volunteer at Thai Freedom House where she serves as a mentor. Her vegan social enterprise, Free Bird Cafe is highly successful, with visitors both local and international coming to taste the delicious ethnic food and support the cause. 100% of the profits from the restaurant are donated to the learning center.
She also serves her community as an intuitive healer and performs one on one healing sessions, particularly with women who have suffered trauma, through her business Lisa Byrd Collection. In addition, she runs Chiang Mai's only donation center accepting clothing and household items year round, which are sorted and sent across Northern Thailand to communities that are the most in need, as well as running a small thrift store to support those efforts, Pre-Loved Charity Shop. Most recently, in 2018, she has opened Chiang Mai's first zero waste shop, My Best Life CNX which is a package free store, working towards combating the problem of plastic and waste in Thailand.
All of her businesses are Social Enterprises, working on the model of Circular Economy, producing less waste and supporting positive change. Join her as she talks about the structure of this work and how to live more intentionally and authentically through your business model.
Send us a message with any questions about sponsoring the event, tickets or anything else.


text:
< Back to Recommendations
Recommendation: 22
Status: Underway
Implement shipping noise-reduction initiatives and monitoring programs, coordinating with Canadian and U.S. authorities.
Create a program similar to Enhancing Cetacean Habitat and Observation (ECHO) for reducing the impact of noise on Southern Residents in Washington.
Coordinate with the ECHO program on transboundary efforts.
Provide funding to complete an underwater acoustic monitoring network for Puget Sound, filling in gaps, such as south San Juan Island, and supporting acoustic and visual mapping to improve the ability to identify when and where Southern Residents are present.
Implementation Details
The Governor should continue to encourage strategic U.S. and Washington State collaborations with ECHO from the U.S. Coast Guard, Washington State Ferries, Puget Sound ports, the Pacific Merchants Shipping Association, the Puget Sound Pilots, OrcaSound, tribes, and others, that support implementation of ECHO and related shipping noise-reduction initiatives while promoting safe, sustainable shipping practices.
Work with the Washington Public Ports Association to create a program similar to ECHO for Washington State. The Governor and the Legislature should fund the deployment of a permanent, scientific-grade hydrophone on south San Juan Island and fill in other key gaps in the underwater acoustic monitoring network of Puget Sound.
The Governor and the Legislature also should support advancement of acoustic and visual mapping efforts by Washington State Ferries and others, with the goal to share data with the Southern Resident Killer Whale Report Alert System being developed in Canada by ECHO and the Vancouver Aquarium.
In 2022, Quiet Sound was funded and began its work to better understand and reduce the cumulative effects of acoustic and physical disturbance from large commercial vessels on Southern Residents in Washington. Quiet Sound's leadership committee comprises National Oceanic and Atmospheric Administration, US Coast Guard, the Makah Tribe, Northwest Indian Fisheries Commission, Puget Sound Partnership, Washington State Ferries, Ports of Seattle and Tacoma, Northwest Seaport Alliance, Washington Maritime Blue, Marine Exchange of Puget Sound, Pacific Merchant Shipping Association, Seattle Aquarium and Natural Resources Defense Council.
During the past few years, ships leaving Washington ports have shown a high degree of compliance with the ECHO program's voluntary slow-downs and other measures in the Strait of Juan de Fuca and Haro Strait/Boundary Pass. Similarly, the U.S. Coast Guard's Vessel Traffic Service actively has encouraged compliance by outbound U.S. and Canadian ships with Canada's interim sanctuary zone at Swiftsure Bank. By minimizing potential encroachment and transits across the sanctuary, the maritime community seeks to minimize underwater noise and disturbance near key Southern Resident foraging hotspots.
The Coast Guard is evaluating safe access routes for vessels traveling to and from West Coast ports from Washington to California to determine whether a Shipping Safety Fairway or routing measures should be created or changed.
More details may be found in the progress reports in the resources library.
Back to Recommendations


crusher motor rotor devanado - drkpolytechnicorg crusher motor rotor devanado; Crusher Wikipedia The electric motor of the cone crusher drives the .
crusher motor rotor devanado ... When the fine impact crusher works, the motor drives the rotor rotate of the impact crusher machine with high speed, ... get price .


text:
package org.scalajs.testsuite.javalib.util.function

import java.util.function.IntSupplier

import org.junit.Assert._
import org.junit.Test

class IntSupplierTest {
  import IntSupplierTest._

  @Test def getAsInt(): Unit = {
    assertEquals(Int.MinValue, makeSupplier(Int.MinValue).getAsInt())
    assertEquals(1024, makeSupplier(1024).getAsInt())
    assertEquals(Int.MaxValue, makeSupplier(Int.MaxValue).getAsInt())
  }
}

object IntSupplierTest {
  def makeSupplier(f: => Int): IntSupplier = {
    new IntSupplier {
      def getAsInt(): Int = f
    }
  }
}

redpajama_set_name: RedPajamaGithub


Obtenga el libro de Seeing Other People (English Edition) de Mike Gayle en formato PDF o EPUB. Puedes leer cualquier libro en línea o guardarlo en tus dispositivos. Cualquier libro está disponible para descargar sin necesidad de gastar dinero.
But, if Joe really has just cheated, why can't he remember anything about it?
Confused but mortified Joe vows to be a better husband and father. Until his wife Penny puts two and two together and leaves him.
Devastated, Joe will do anything to win his family back. But when he realises that the key to saving his marriage lies in the hands of the mean-spirited ghost of his least favourite ex-girlfriend, Joe knows he's in real trouble.
SEEING OTHER PEOPLE is a hilarious and bittersweet novel about love, parenthood and fidelity and how easy it is to get lost on the way to your own happy ending.
From My Legendary Girlfriend to Turning Forty, Mike Gayle's bestselling novels have taken his millions of readers through many key times for the modern man - friendship, courtship, stag weekends, marriage, work, holidays, significant birthdays - but SEEING OTHER PEOPLE is perhaps his most heart-warming, heart-stopping, heartbreaking novel yet.


text:
Sparasion bilaminatum är en stekelart som beskrevs av Marshall 1913. Sparasion bilaminatum ingår i släktet Sparasion och familjen Scelionidae. Inga underarter finns listade i Catalogue of Life.

Källor

Steklar
bilaminatum


text:
FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in U.S. with Acute COVID-19
SAN FRANCISCO, June 23, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 Study investigating the efficacy and safety of pamrevlumab in hospitalized patients with acute coronavirus 2019 (COVID-19) infection. This multicenter trial is being conducted in the U.S. and will enroll approximately 130 patients with COVID-19.
The primary objective of this study is to assess the effect of pamrevlumab on blood oxygenation in patients with COVID-19 infection, and patients will be randomized to treatment with pamrevlumab or standard of care in a 1:1 ratio. The primary efficacy assessment is the proportion of hospitalized COVID-19 patients who have not received mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO) and remain alive at Day 28.
"The majority of patients with severe forms of COVID-19 have bilateral interstitial pneumonia, causing reduction in oxygenation and severe respiratory failure," said Elias Kouchakji, M.D., Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance, FibroGen. "The administration of pamrevlumab, a first-in-class anti-connective growth factor monoclonal antibody, could protect the lung from the immediate consequences of the infection presented as acute respiratory distress syndrome."
A second planned U.S. trial is expected to assess the longer term efficacy and safety of pamrevlumab in patients who have recovered or are recovering from COVID-19 infection with evidence of interstitial lung disease.
Pamrevlumab is a first-in-class antibody developed by FibroGen to inhibit the activity of CTGF, a common factor in fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure. This trial will assess pamrevlumab's effect on patient time to and on ventilatory support, currently the most urgent need, and its potential to reduce mortality and fibrotic sequelae in the lung.
"Given our expertise in CTGF biology and the potential application of this unique approach to the treatment of patients with acute COVID-19 infection, we are excited to begin enrolling this trial in the U.S." said Enrique Conterno, Chief Executive Officer, FibroGen. "We are grateful for the collaboration of the FDA, investigators, and patients in enabling the conduct of this trial."
About Pamrevlumab
Pamrevlumab is a first-in-class antibody developed by FibroGen that inhibits the activity of connective tissue growth factor (CTGF), a common factor in fibrotic and proliferative disorders. Pamrevlumab is in Phase 3 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF) and locally advanced unresectable pancreatic cancer (LAPC), and in Phase 2 clinical development for the treatment of Duchenne muscular dystrophy (DMD) and coronavirus (COVID-19). For information about pamrevlumab studies currently recruiting patients, please visit www.clinicaltrials.gov.
About FibroGen
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines to treat unmet needs. The Company is currently developing and commercializing roxadustat, an oral small molecule inhibitor of HIF prolyl hydroxylase activity, for anemia associated with chronic kidney disease (CKD). Roxadustat is also in clinical development for anemia associated with myelodysplastic syndromes (MDS) and for chemotherapy-induced anemia. Pamrevlumab, an anti-CTGF human monoclonal antibody, is in clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), locally advanced unresectable pancreatic cancer, Duchenne muscular dystrophy (DMD), and coronavirus (COVID-19). For more information, please visit www.fibrogen.com.
Source: FibroGen, Inc


text:
Q: Ubuntu 18.04.2 LTS on ESXi 6.7 white screen after boot I am trying to install 18.04.2 LTS Server on ESXi 6.7.
I get to the boot menu, select the language and start the installation.
Next thing is I get a pretty bright screen with artifacts.
When I try to use the text based installer It warns me about the incomplete translation and when I accept, the screen stays the same and I can't do anything anymore.

*

*I exposed all CPU features

*I increased the graphical memory size from 4 up to 64

*I enabled 3D acceleration

*I set booting to UEFI

Nothing helped.
The VMs have >4GB RAM, 2 and 4 cores, 20-32 GB HDD for the primary hard drive on SSD.

*

*I re-downloaded the server (not live) installation ISO

*I tried starting the VM without optical drive attached, attaching it at runtime and sending CTRL+ALT+DEL as we had experiences with other VMs on different servers not detecting devices (HDD for example) correctly without this procedure (ESXi 6.5)

I can't get the installation started and these machines will be mission critical and I have no idea whats causing this.
Thanks much for any help.

redpajama_set_name: RedPajamaStackExchange


text:
Symposium Keynotes
Role of Academia
George Daley, M.D, Ph.D.
Dean, Harvard Medical School
As the dean of Harvard Medical School, the Caroline Shields Walker Professor of Medicine at HMS, and a former investigator of the Howard Hughes Medical Institute until he resigned upon assuming deanship 2017, George Q. Daley's career spans basic science and clinical medicine. He is an internationally recognized leader in stem cell science and cancer biology, having served as president of the International Society for Stem Cell Research (2007-08) and having testified before Congress on the ethical dimensions of stem cell research and its promise in treating disease. A full professor at HMS since 2010 and the inaugural winner of the National Institutes of Health Director's Pioneer Award for highly innovative research (2004), his laboratory focuses on the use of mouse and human disease models to identify mechanisms that underlie blood disorders and cancer. Prior to his role as dean of Harvard medical School, he was the director of the Pediatric Stem Cell Transplantation Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the Samuel E. Lux, IV Chair in Hematology/Oncology at Boston Children's Hospital.
Peter Kolchinsky, PhD.
Founder & Managing Director, RA Capital
Co-Founder, Harvard Biotech Club
Peter Kolchinsky (Ph.D '01) is co-founder, Managing Director, and Portfolio Manager of RA Capital Management, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life science companies. He is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves as a member of the Board of Directors for a number of private companies. He is the author of "The Entrepreneur's Guide to a Biotech Start-up" and the Biotech Social Contract series.
Promise of Industry
David Altshuler, M.D, Ph.D.
EVP & CSO, Vertex Pharmaceuticals
David Altshuler is the Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals, and a Chair on the scientific advisory board of the Wellcome Trust Sanger Institute. Previously, David was a professor of Genetics and of Medicine at Harvard Medical School and an endocrinologist at Massachusetts
General Hospital. He co-founded the Broad Institute of MIT and Harvard in 2004 and served as its Deputy Director and Chief Academic Officer for over 10 years. As a geneticist, he was a leader of multiple large scale genetic projects, and discovered over 100 gene variants associated with type 2 diabetes and other common diseases. David is also a member of the National Academy of Medicine and the American Academy of Arts and Sciences, and was named a Champion of Change by the White House for his leadership in creating and leading the Global Alliance for Genomic and Health.
Perspectives from Entrepreneurial PIs
George Church ● Pardis Sabeti ● David Walt ● Pam Silver ● Sangeeta Bhatia
Moderated by: Meredith Fisher
George M. Church is professor of genetics at Harvard Medical School, a founding member of the Wyss Institute, and director of PersonalGenomes.org, the world's only open-access information on human genomic, environmental, and trait data. He is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. He developed the first methods for the first genome sequence and dramatic cost reductions since then (down from $3 billion to $600), contributing to nearly all "next generation sequencing" methods and companies. His honors include the Franklin Bower Laureate for Achievement in Science, the Time 100, and election to the National Academies of Sciences and Engineering. His many innovations have been the basis for 514 papers, 143 patent publications, and founder of 28 companies.
Pardis Sabeti is a computational geneticist with expertise developing algorithms to detect genetic signatures of adaption in humans and the microbial organisms that infect humans. Dr. Sabeti completed her undergraduate degree at MIT, her graduate work at Oxford University as a Rhodes Scholar, and her medical degree summa cum laude from Harvard Medical School as a Soros Fellow. Dr. Sabeti is a World Economic Forum (WEF) Young Global Leader and a National Geographic Emerging Explorer, and was named a TIME magazine 'Person of the Year' as one of the Ebola fighters. Her awards included the Smithsonian American Ingenuity Award for Natural Science, the Vilcek Prize for Creative Promise, the NIH Innovator Award, the Packard Fellowship, and an Ellis Island Medal of Honor. She has served on the MIT Board of Trustees and the National Academy of Sciences Committee on Women in Science, Medicine, and Engineering. Dr. Sabeti additionally provides scientific guidance as a board member and investor of NextGen Jane, a women's health company launched by two lab alumni, and is one of the co-founders of SHERLOCK Biosciences, a company dedicated to improving health worldwide through accurate, fast and affordable testing.
David Walt is an internationally-recognized expert in nanoscience and diagnostics and has invented numerous transformative technologies that have led to major commercial successes. David has had a highly successful academic career combined with significant entrepreneurial activity. He is a member of the faculty at Harvard Medical School, a member of the faculty in Pathology at Brigham and Women's Hospital, is a Member of the Wyss Institute at Harvard University and is a Howard Hughes Medical Institute Professor. Notably, he is the Scientific Founder of Illumina and served on the Board of Illumina for 18 years. David is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He has published over 350 peer-reviewed papers, has over 100 issued US patents, and has received numerous national and international awards and honors
Pamela Silver is one of the founding members of the Department of Systems Biology at Harvard Medical School and was the first Director of the Harvard University Graduate Program. Her work was recognized by an Innovation Award at BIO2007 and has been recognized by an Established Investigator of the American Heart Association, a Research Scholar of the March of Dimes, an NSF Presidential Young Investigator Award, Claudia Adams Barr Investigator, an NIH MERIT award, the Philosophical Society Lecture, a Fellow of the Radcliffe Institute, and election to the American Academy of Arts and Sciences. She is among the top global influencers in Synthetic Biology and her work was named one of the top 10 breakthroughs by the World Economic Forum. She serves on numerous public and private advisory boards including the board of the Internationally Genetics Engineering Machines (iGEM) Competition, and she is the co-founder of several biotech companies.
Sangeeta Bhatia is a Howard Hughes Medical Institute Investigator and Professor at MIT. Additionally, she is an Associate Faculty at the Wyss Institute, Affiliated Faculty member of the Harvard Stem Cell Institute, an Institute Member of the Broad Institute, a Biomedical Engineer at the Brigham & Women's Hospital, and a board member of both Brown University and Vertex Pharmaceuticals. Trained as both a physician and engineer at Harvard, MIT, and Brown University, Dr. Bhatia's laboratory leverages 'tiny technologies' of miniaturization to yield inventions with new applications in tissue regeneration, stem cell differentiation, medical diagnostics, predictive toxicology, and drug delivery. She and her over 150 trainees have contributed to more than 50 issued or pending patents and have launched more than 10 biotechnology companies to improve human health.
Meredith Fisher is a Partner with the Innovation Fund focusing on early stage investments and company creation. Previously, she was in the private/family office at Bracebridge Capital serving as Director of Private Investments where she led investments in early stage life science companies. Prior to that role she led business development for Ginkgo BioWorks- an MIT spin out- and was Senior Director of Technology and Business Development of Enlight Biosciences- a venture creation company founded by PureTech Ventures. She spent several years working as a scientist in drug discovery and assay development for Idenix Pharmaceuticals and Anadys Pharmaceuticals (formerly, Scriptgen). Meredith received her undergraduate degree from Mount Holyoke College, her MBA from the MIT Sloan School of Management and her PhD from Harvard University. While at Harvard, she co-founded Harvard Graduate Women in Science and Engineering (HGWISE). Meredith is a member of the Board of Directors at Metera and she represents the fund on the boards of Nocion and Mediar Therapeutics, and as a board observer at Lyndra. She is the 2019-2020 co-chair of WEST (Women in the Enterprise of Science and Technology) and serves as an advisor to Takeda HATCH.
Human Genetics as the Gateway to Industry-Academic Collaborations
Ana Greka ● Sek Kathiresan ● Caroline Fox ● Morgan Sheng
Moderated by: Daniel McArthur
Anna Greka is a physician-scientist and associate professor at Harvard Medical School and an institute member of the Broad Institute of MIT and Harvard, where she directs the institute's Kidney Disease Initiative. She is also an associate physician in the Renal Division in the Department of Medicine at Brigham and Women's Hospital (BWH); and the founding director of Kidney-NExT, a Center for Kidney Disease and Novel Experimental Therapeutics at BWH and HMS. She is also a cofounder at Goldfinch Bio, a Third Rock Ventures-funded early stage biotech focused on the development of therapeutics for severe kidney diseases. At the Broad Institute, her team focuses on understanding the mechanistic underpinnings for development of targeted therapeutics.
Sek Kathiresan is the CEO of Verve Therapeutics, a GV and Verily funded biotech startup focused on developing therapeutics for heart disease risk. Previously, he was a professor of medicine at Harvard Medical School and an institute member at the Broad Institute, where he directed the Cardiovascular Disease Initiative and co-directed the Program in Medical and Population Genetics. During this time, he was also the director of the Center for Genomic Medicine at Massachusetts General Hospital. Sek is widely regarded as a leader in developing statistical methods to study the genetics of heart diseases. His laboratory's work has highlighted mechanisms underlying heart attack, discovered mutations that protect against heart attack risk, and pioneered the use of polygenic risk scores to identify individuals at high-risk for heart attack.
Caroline Fox is the Vice President and Head of Genetics and Pharmacogenomics at Merck Research Laboratories in Boston, where she works on drug discovery using human discovery genetics and molecular profiling in immuno-oncology. Prior to joining Merck, Caroline worked at the National Institutes of Health (NIH) where she was involved with the Framingham Heart Study, studying metabolic risk factors for cardiovascular disease, and was an associate editor at Circulation. In addition to her role as VP at Merck Research Labs, she has also been as associate professor in Medicine at Brigham and Women's Hospital since 2010.
Morgan Sheng has extensive research experience in both industry and academia, having spent several years as a faculty member at Massachusetts General Hospital and Harvard Medical School before becoming appointed as the Menicon Professor of Neuroscience at MIT and an investigator at the Howard Hughes Medical Institute. He then moved to and spent nearly a decade as the vice-president of neuroscience at Genentech, where he led research and drug discovery efforts for major diseases of the nervous system. Morgan Sheng returned to academia in 2019, and is currently a professor of neuroscience in MIT's Department of Brain and Cognitive Sciences, and an institute member of the Broad Institute of MIT and Harvard, where he serves as co-director of the Broad's Stanley Center for Psychiatric Research.
Daniel MacArthur is an associate professor at Harvard Medical School and an institute member of the Broad Institute of MIT and Harvard, and a group leader in the Analytic and Translational Genetics Unit at Massachusetts General Hospital. He is also cofounder of Goldfinch Bio, a Third Rock Ventures-funded early stage biotech focused on the development of therapeutics for severe kidney diseases. The MacArthur laboratory has lead the use of big data in human genetics, having assembled the largest collection of sequences of the protein-coding region of the human genome, creating a resource called the Genome Aggregation Database (gnomAD). MacArthur was recognized for his work with the Harvard Medical School's Young Mentor Award in 2016, the Massachusetts General Hospital Martin Prize in 2017, and was also the first ever recipient of the American Society of Human Genetics Early-Career Award in 2017.


text:
Boyden Recruits CHRO for Solotech
August 23, 2019 – Anyone with the ties to the human resources function knows how much it has evolved in recent years, and with it the role of the chief human resources officer. The biggest shift has been in how the CHRO has progressed from fighting for a seat at the table to playing a key role on the executive team. According to executive recruiters who place some of the best talent in the field, a great CHRO can be among the most vital strategic human assets a company can have – closely partnering with the CEO and CFO.
Recently, executive search firm Boyden placed Claudine Ricard as the new CHRO of Solotech in Montreal.
"Ms. Ricard will be a great addition to our leadership team," said Martin Tremblay, president and CEO of Solotech. "With her strategic vision, her broad HR and M&A background, her international experience, along with her passion for talent, she will undoubtedly play a key role in supporting Solotech's accelerated growth and evolving business on a global scale. I look forward to working with her."
Ms. Ricard joins Solotech with 25 years of experience in various HR roles in large publicly traded organizations. In her most recent role, she was vice president of culture and talent at TC Transcontinental, where she headed the global talent function and implemented the talent and diversity strategy with a focus on leadership succession. Prior to that, she worked 19 years for CGI in various HR leadership positions including as vice president of culture and experience, VP of organizational development and leadership institute and VP of HR integration center of expertise, where she led all HR aspects of mergers and acquisitions. Earlier in her career, Ms. Ricard also worked at Honeywell Aerospace, where she was responsible for all aspects of HR.
In addition, Ms. Ricard is an active mentor in the wider HR community and devotes a good deal of time outside of work as a coach to other HR professionals. She is also a certified human resources professional (CHRP), a member of the Cercle des Leaders RH and a board member of Intégration Jeunesse du Québec.
New Role
Joining Solotech's executive team as well as the board HR committee, Ms. Ricard will lead the company's people and culture strategy while being a key contributor to the rapid and international expansion of the business. She will be responsible for all aspects of human resources functions globally, including talent management, leadership and organizational development, learning, compensation and benefits. Ms. Ricard is charged with continuing to build a culture that focuses on attracting, retaining and developing the best talent, as Solotech solidifies its position as a worldwide leader in audiovisual and entertainment technology and an employer of choice.
Founded over 40 years ago, Solotech is a world leader in audiovisual and entertainment technology with 13 strategic locations in Canada, the U.S. and Europe. The company employs 1,200 professionals in its offices located in Montreal, Quebec City, Saguenay, Ottawa, Toronto, Las Vegas, Nashville, DeKalb, Los Angeles, Heywood, London and Redditch.
Boyden is a global provider of executive search services, with more than 70 offices in over 40 countries. Founded in 1946, the firm specializes in high-level executive search, interim management and human capital consulting across a broad spectrum of industries.
CHRO Recruiting in the News
Hunt Scanlon Media has tracked a number of CHRO search assignments over the summer. Here's a sampling taken from the company's daily newswire archives:
Tom Phillips and Charlotte Harris of Koya Leadership Partners were recently retained by the University of New England (UNE) to assist in its search for a new CHRO. The university, located in Biddeford, ME, seeks a collaborative and forward-looking human resources leader that will play an important role in building upon the institution's strategic plan, "Our World, Our Future."
Hanold Associates placed Lisa V. Price as the executive vice president and CHRO of Domino's Pizza. Jason Hanold, CEO and co-managing partner of the search firm, led the assignment. He was joined by partners Keri Gavin, Ashley Schiele and Sonia Nagra. Ms. Price most recently served as senior vice president of human resources at Nordstrom.
West Hartford CT-based Academic Career & Executive Search was recently tapped by the Dallas County Community College District (DCCCD) to help find its next CHRO. Jennifer Muller, co-founder and managing partner, is leading the assignment. DCCCD wants a highly accomplished, collaborative leader and change agent with a successful track record in the areas of talent acquisition, development, succession planning, support and management.
Charlotte, NC-based Search Solution Executive placed Scott Conklin as the CHRO at itelligence North America in Cincinnati. President Jeremy Gnozzo led the assignment. Steve Niesman, CEO of itelligence North America, retained the services of Search Solution Executive to locate a CHRO with a very specific background, set of skills and the personality type to lead company culture and change management.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Andrew W. Mitchell, Managing Editor – Hunt Scanlon Media
Check Out These Related Articles On CHROs:
Here's Why Game Changing CHRO Talent Is In Big Demand An Up-Close Look at the Transformational Role of the CHRO Data-Driven CHROs In Demand
Driving Diversity and Inclusion from the Top
Frederickson Partners Recruits Global Head of Talent Acquisition for Nubank


text:
package com.kdstore.order;

import java.util.Date;

public class TransactionOrder {
	private int transOrderId;
	private Date transOrderDate;

	public int getTransOrderId() {
		return transOrderId;
	}
	public void setTransOrderId(int transOrderId) {
		this.transOrderId = transOrderId;
	}
	public Date getTransOrderDate() {
		return transOrderDate;
	}
	public void setTransOrderDate(Date transOrderDate) {
		this.transOrderDate = transOrderDate;
	}
}


text:
package tsdb

import (
	"io/ioutil"
	"math/rand"
	"os"
	"path/filepath"
	"testing"

	"github.com/go-kit/kit/log"
	"github.com/prometheus/tsdb/index"
	"github.com/prometheus/tsdb/labels"
	"github.com/prometheus/tsdb/testutil"
)

// In Prometheus 2.1.0 we had a bug where the meta.json version was falsely bumped
// to 2. We had a migration in place resetting it to 1 but we should move immediately to
// version 3 next time to avoid confusion and issues.
func TestBlockMetaMustNeverBeVersion2(t *testing.T) {
	dir, err := ioutil.TempDir("", "metaversion")
	testutil.Ok(t, err)
	defer os.RemoveAll(dir)

	testutil.Ok(t, writeMetaFile(dir, &BlockMeta{}))

	meta, err := readMetaFile(dir)
	testutil.Ok(t, err)
	testutil.Assert(t, meta.Version != 2, "meta.json version must never be 2")
}

func TestSetCompactionFailed(t *testing.T) {
	tmpdir, err := ioutil.TempDir("", "test")
	testutil.Ok(t, err)
	defer os.RemoveAll(tmpdir)

	b := createEmptyBlock(t, tmpdir, &BlockMeta{Version: 2})

	testutil.Equals(t, false, b.meta.Compaction.Failed)
	testutil.Ok(t, b.setCompactionFailed())
	testutil.Equals(t, true, b.meta.Compaction.Failed)
	testutil.Ok(t, b.Close())

	b, err = OpenBlock(tmpdir, nil)
	testutil.Ok(t, err)
	testutil.Equals(t, true, b.meta.Compaction.Failed)
}

// createEmpty block creates a block with the given meta but without any data.
func createEmptyBlock(t *testing.T, dir string, meta *BlockMeta) *Block {
	testutil.Ok(t, os.MkdirAll(dir, 0777))

	testutil.Ok(t, writeMetaFile(dir, meta))

	ir, err := index.NewWriter(filepath.Join(dir, indexFilename))
	testutil.Ok(t, err)
	testutil.Ok(t, ir.Close())

	testutil.Ok(t, os.MkdirAll(chunkDir(dir), 0777))

	testutil.Ok(t, writeTombstoneFile(dir, newMemTombstones()))

	b, err := OpenBlock(dir, nil)
	testutil.Ok(t, err)
	return b
}

// createPopulatedBlock creates a block with nSeries series, filled with
// samples of the given mint,maxt time range.
func createPopulatedBlock(tb testing.TB, dir string, nSeries int, mint, maxt int64) *Block {
	head, err := NewHead(nil, nil, nil, 2*60*60*1000)
	testutil.Ok(tb, err)
	defer head.Close()

	lbls, err := labels.ReadLabels(filepath.Join("testdata", "20kseries.json"), nSeries)
	testutil.Ok(tb, err)
	refs := make([]uint64, nSeries)

	for ts := mint; ts <= maxt; ts++ {
		app := head.Appender()
		for i, lbl := range lbls {
			if refs[i] != 0 {
				err := app.AddFast(refs[i], ts, rand.Float64())
				if err == nil {
					continue
				}
			}
			ref, err := app.Add(lbl, int64(ts), rand.Float64())
			testutil.Ok(tb, err)
			refs[i] = ref
		}
		err := app.Commit()
		testutil.Ok(tb, err)
	}

	compactor, err := NewLeveledCompactor(nil, log.NewNopLogger(), []int64{1000000}, nil)
	testutil.Ok(tb, err)

	testutil.Ok(tb, os.MkdirAll(dir, 0777))

	ulid, err := compactor.Write(dir, head, head.MinTime(), head.MaxTime(), nil)
	testutil.Ok(tb, err)

	blk, err := OpenBlock(filepath.Join(dir, ulid.String()), nil)
	testutil.Ok(tb, err)
	return blk
}


On Feb. 1, Tarique Plummer officially became Wilfrid Laurier University's newest Students' Union president and CEO.
Plummer ran on a campaign platform of "community cohesion and helping others" — committing to different series of initiatives which aim to change the way students interact with the university.
Winning the election with 52.35 per cent of the votes, Plummer is committed to following through on his campaign initiatives — ones he says were put forward by the student body.
"When I was developing my platform, the ideas that came about are not essentially mine," Plummer said.
Working alongside Plummer is the new Chair and CGO of the Board of Directors, Adam Kovacs.
Both Plummer and Kovacs have begun working hard in the summer months — getting comfortable in their new positions and preparing for the upcoming academic year.
Kovacs also reports a similar plan for the summer.
Moving into his new role, he plans to orient himself and jump right into work.
"I've been in the office every single day practically. Talking to the staff, seeing what they do, talking to the former chairs — just seeing exactly what they did and getting to know the people in the office," Kovacs said.
In his message to the student body, Plummer lists the fifteen initiatives put forward to enhance the student experience at Laurier. In regards to which of the fifteen will be at the forefront of the fall semester, Plummer says there is no simple answer.
"What I've done so far is delegate different platform initiatives based on nature to each vice president," Plummer also said.
Plummer noted that there are three major pieces he is looking forward to: accomplishing what the students elected him to do, building relationships with fellow students and the uncertainty that awaits him in his new position and the entire organization. Coming into his new position, Kovacs says that he is most excited for the board.
Looking forward, an initiative like the integration of the Wellness Centre will be put in motion later in the year — Plummer hopes it will be brought to the students around next year's election period as a referendum question.
Currently, Plummer reports that the Student Ambassador Program is already in the works and has opened up for executive positions.
Overall, Plummer plans to release a monthly report to the student body, keeping track of the changes and programming that will come.
When asked about his own priorities as Chair, Kovacs says the elections are his main focus.
"I'm starting early. I'm thinking about what exactly we can do and how we can increase our voter turnout," Kovacs said.
On May 12, the Students' Union held their first official meeting with Plummer and Kovacs in their new positions.
Both Plummer and Kovacs were happy to report that the meeting went extremely well.
"I, as a two time board director, former director, and former chair of the board was thoroughly impressed with the level of professionalism, with the keenness of the directors and with the quality of the questions that we asked at that table," Plummer said.
Kovacs also noted the quality of discussions and questions brought forward in the meeting, and that the overall experience was indicative of a great year.
"It was a very quick meeting," Kovacs said.
When asked about the recent exposure Laurier has received regarding various students and clubs, and the tough conversations the school has had to have, Kovacs and Plummer gave insight into how the new leaders within the Students' Union will be moving forward.
When the beliefs and opinions on campus vary greatly, Kovacs states the role of the Students' Union is to remain neutral.
Moving closer to the academic year, Laurier's new leaders express what they are most excited for.
Plummer noted that there are three major pieces he is looking forward to: accomplishing what the students elected him to do, building relationships with fellow students and the uncertainty that awaits him in his new position and the entire organization.
Coming into his new position, Kovacs says that he is most excited for the board.
"It's a great year because we are all fresh out the gate, everyone is getting along, everyone's excited and we're having a lot of fun. Our goal this year is to help the student body, and we are going to make sure that happens," Kovacs said.